Northern Kentucky Dangerous Drugs | Yaz Yasmin Injuries

By Author: Hendy Johnson
Total Articles: 25
Comment this article

Serious side effects and health problems caused by Yaz and Yasmin birth control have impacted women across the country. Yaz and Yasmin birth control pills have an ingredient called drospirenone, which is not found in other forms of birth control in the United States.

Drospireonone is a synthetic progestin that can increase blood potassium levels. Too much potassium in the blood can result in a condition known as hyperkalemia, leading to blood clots, heart attacks or stroke.Women who already have high levels of potassium in their blood are especially at risk of suffering serious health problems from Yaz or Yasmin. Also, women who are taking medications that could increase potassium levels, such as Heparin, Motrin, Aleve or Advil, could be in danger.

Yaz is manufactured by Bayer USA and is one of the top selling birth control pills on the market. This drug was approved by the U.S. Food and Drug Administration (FDA) in March 2006 and has been under scrutiny for its TV commercials that downplayed the potential adverse health effects. In October 2008, the FDA found two Yaz commercials to be deceptive and sent a ...
... warning letter to the manufacturer.

Many women have reported that Yaz and Yasmin caused them to suffer serious health problems. As a result, numerous lawsuits have been filed against Bayer. Some of the reported medical conditions include:

Heart attack
Stroke
Pulmonary embolism
Kidney disease
Deep vein thrombosis
Death

If you have suffered a serious illness or medical condition from taking the birth control, Yaz or Yasmin, you may be able to pursue compensation for your injuries. Contact an experienced Northern Kentucky injury lawyer at the Law Office of Schachter, Hendy & Johnson at (859) 578-4444 or (888) 606-5297 for more information.

For More Info : Visit Here : https://justicestartshere.com/

We are excited to continue our growth and expand our resources with the addition of Jay Vaughn and the promotion of Sarah Emery to join the firm’s partnership.